Abbott to Cut 3,000 Jobs After Solvay Unit Acquisition

Abbott Laboratories said it’s announcingd a restructuring plan related to its acquisition of Solvay’s pharmaceuticals business. The information was disclosed in a regulatory filing.

To contact the editor responsible for this story: Bill Koenig at wkoenig@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.